Call 888-776-0942 from 8 a.m. to 10 p.m. Eastern Time

Atlanta, November 17, 2021/PRNewswire/ - ProgenaCare Global (formerly Cell Constructs) has developed innovative products for wound healing that can provide patients with excellent treatment results while advancing the use of renewable materials. The company's wound care technology ProgenaMatrix™ uses human keratin as the main component of efficient and affordable wound treatment.

The all-natural strong human keratin option that makes up this special biomaterial provides a completely unique solution for wound care clinicians. The human keratin technology in ProgenaMatrix is ​​hydrated, non-cellular (not tissue-based), non-absorbable, and supports the body's own healing process. The bionic design makes ProgenaMatrix the next-generation advanced wound therapy in the CMS skin replacement category.

Keratin technology has a history of more than a century in published literature, and its applications in wound healing, drug delivery, tissue engineering, trauma and medical devices. 1 These studies inspired Progenacare to seek the application of keratin as a wound dressing. Studies have shown that keratin stimulates keratinocyte migration and collagen synthesis, which is important for re-epithelialization of the wound bed. Keratin stimulates keratinocytes in vitro to produce increased type IV and type VII collagens, which are the core of the basement membrane remodeling during the healing process. 2

"The ability to use unique human-derived materials that are safe and removed through the 510(k) process may revolutionize the industry. The use of human keratin instead of typical collagen provides healthcare professionals with more effective advanced treatment options for acceleration Closure of chronic wounds."-Ryan Chatelain, DPM

"For hard-to-heal wounds, ProgenaMatrix has proven to be a revolutionary game changer in the industry. It is fast, effective, patient tolerable and easy to use."-Bheki Khumalo, DPM.

Participate in a webinar with Dr. Khumalo to discuss some recent patients he treated on Thursday, November 18, 2021 at 6 pm (Eastern Standard Time). Go to register: https://go.progenacare.com/l/926933/2021-10-13/tv12

ProgenaCare Global is a multidisciplinary company focused on global wound care solutions. It was founded in 2008 by biopolymer scientist Dr. Tom Barrows and medical device entrepreneur John Daniel, with the main funding coming from Bert Jones. For information, please call (770) 627-2547. 2275 Northwest Pkwy SE Suite 170, Marietta, GA 30067. www.ProgenaCare.com

1. Rouse JG, Van Dyke ME. Overview of keratin biomaterials for biomedical applications. Materials, 2020, 2, 999-1014.

2. Tang L, Sierra JO, Kelly R, Kirsner RS, Li J. Wool-derived keratin stimulates human keratinocyte migration and type IV and type VII collagen expression. Experimental Dermatology, 2021, 21, 456-476.

More news releases on similar topics

Cision Distribution 888-776-0942 8 a.m. to 9 p.m. Eastern Time